Skip to main content
. 2021 Jan 5;10(1):164. doi: 10.3390/jcm10010164

Table 4.

HBV reactivation prophylactic strategies according to risk category.

Risk Category Preventive Strategy Recommended
EASL Guidelines (2017) AGA Guidelines (2015)
High (>10%) Entecavir or tenofovir if HBsAg+
Lamivudine if HBsAg-/antiHBc+		 Entecavir or tenofovir
Moderate (1–10%) Pre-emptive therapy Entecavir or tenofovir
Low (<1%) Pre-emptive therapy Pre-emptive therapy

EASL: European Association for the Study of the Liver, AGA: American Gastroenterological Association, HBsAg: hepatitis B surface antigen, antiHBc: hepatitis B core antibodies.